Roche collaborates with Nurix Therapeutics to develop BTK degrader bexobrutideg for cancer and immune diseases
Agreement expands Roche’s oncology pipeline with a potential best in class targeted protein degrader for B cell malignancies and beyond
Agreement expands Roche’s oncology pipeline with a potential best in class targeted protein degrader for B cell malignancies and beyond
Neurological disorder research is evolving from single cells to complex networks thanks to 3D brain cultures and multielectrode arrays
New drug testing panel supports rapid, automated screening of 15 drugs of abuse in clinical and critical care settings
Expansion reflects broader effort to scale advanced testing capabilitie across Vitalant’s network
Rapid pre-cooling technology supports high-throughput and energy-efficient workflows
NVIDIA-powered AI capabilities enable proactive laboratory optimization
See how the Laboratory of Mucosal Immunology at KU Leuven uses flow cytometry and cell sorting to advance our understanding and uncover new therapeutic targets for chronic gastrointestinal diseases